Providing services to benefit the Pharmacy profession

Facebook Twitter

It contains dry ivy leaf extract (Hedera Helix) that has expectorant and spasmolytic actions. It is indicated for: Acute inflammation of the respiratory tract and for the improvement of symptoms of chronic-inflammatory bronchial disease. SEP price incl VAT is R45.00

MSD has launched of JANUVIA® (25 mg, 50 mg, 100 mg daily), a new oral antidiabetic agent for the treatment of type 2 diabetes.

JANUVIA® contains sitagliptin, a dipeptidyl peptidase 4 (DPP-4) inhibitor (incretin enhancer) that increases the levels of two incretin hormones, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP). These hormones play a major physiological role in maintaining glucose homeostasis.

Sitagliptin is the most widely prescribed DPP-4 inhibitor worldwide, with over 46 million prescriptions dispensed for the sitagliptin family. JANUVIA® has been launched in 107 countries and boasts clinical data of up to 2 years in duration. Sitagliptin in combination with metformin has a lower risk of hypoglycaemia and leads to weight loss versus a sulphonylurea plus metformin.

Should you have any further queries please contact Sarojini Moodley (Diabetes Franchise Brand and Customer Manager):

sarojini_moodley@merck.com

(011) 655 3117

 

Novartis South Africa is pleased to announce the introduction of Galvus®Met effective from 17 October 2012. This is in addition to the Galvus® range, enhancing their metabolic portfolio.

Here are the Galvus®Met options: Galvus Met 50mg/850mg tablets in 30’s and 60’s Galvus Met 50mg/1000mg tablets in 30’s and 60’s

Astellas Pharma has discontinued the 100g pack size of Locoid Crelo. However, the Locoid Crelo 30g pack size is still available.

n a concerted effort to ensure excellence and the successful implementation of the goals set in the Human Resources for Health Strategy, the Minister of Health, Dr Aaron Motsoaledi will on Tuesday, 6 November launch the Academy for Leadership and Management in Health Care to address skills gaps at all levels, including clinical and hospital management.

In 2011 Health Minister Dr Aaron Motsoaledi commissioned a study to review competency levels of hospital Chief Executive Officers, a move towards overhauling the health system in South Africa and it was evident that “a significant proportion did not have the requisite leadership and management competencies”.

http://www.doh.gov.za/show.php?id=3787

Proudly powered by WordPress